# RIVAROXABAN
> **ANDA212220** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2022-06-27
## Drug
- **FDA Application Number:** ANDA212220
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVAROXABAN
- **Generic name:** Rivaroxaban
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMS INC
- **First approval:** 2022-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212220)
---
*MORVS · CC0 1.0*